Abstract: A crystalline carbazole derivative, pharmaceutical compositions thereof, and methods of treatment are provided herein.

Abstract: The present disclosure provides methods for the treatment of lipid-related disorders. In some embodiments, the method is a method of reducing the quantity of adipose tissue in need thereof, comprising administering a plurality of injections of the pharmaceutical compositions provided herein.

Abstract: Embodiments relate to a tablet comprising celecoxib and ciprofloxacin or a pharmaceutically acceptable salt thereof, and low viscosity hydroxypropyl methylcellulose having a viscosity of less than 150 cP, when measured as a 2% solution in water at 20° C.

Abstract: An array antenna configured to be placed at a determined position above the ground surface. The array antenna is assembled by a plurality of unmanned aerial vehicles (UAVs), each UAV carrying one or more antenna elements of the array antenna. The plurality of UAVs configured to create a defined formation at the determined position above the ground and thereby align the one or more antenna elements carried by the UAVs to form the array antenna. The array antenna configured to receive electromagnetic signals reflected from a region of interest, or from one or more objects, within its line of sight.

Abstract: An array antenna configured to be placed at a determined position above the ground surface. The array antenna is assembled by a plurality of unmanned aerial vehicles (UAVs), each UAV carrying one or more antenna elements of the array antenna. The plurality of UAVs configured to create a defined formation at the determined position above the ground and thereby align the one or more antenna elements carried by the UAVs to form the array antenna. The array antenna configured to receive electromagnetic signals reflected from a region of interest, or from one or more objects, within its line of sight.

Abstract: The present disclosure includes a body-worn alcohol detection device. The device includes a housing comprising an electronics module and an alcohol detection module. The device further comprises a strap for securing the housing to a limb of the user. The electronics module includes a processor and a communication module, and the alcohol detection module includes an alcohol detection sensor, a sample collection device and a biometric camera for capturing an image of the inside of the user's mouth.

Abstract: The present disclosure includes a body-worn alcohol detection device. The device includes a housing comprising an electronics module and an alcohol detection module. The device further comprises a strap for securing the housing to a limb of the user. The electronics module includes a processor and a communication module, and the alcohol detection module includes an alcohol detection sensor, a sample collection device and a biometric camera for capturing an image of the inside of the user's mouth.

Abstract: An application provides a search box that is configured to enable a user to enter searchable text. The application provides a quick pick search provider menu that is configured to include different sections that provide suggestions as text is entered into the search box. At least some of the suggestions are locally maintained, and at least some other of the suggestions are received from one or more remote search providers. In some embodiments, the application can comprise a web browser.

Abstract: Various embodiments enable information, in addition to textual information, to be presented to a user when the user enters a search query in a search box forming part of a user interface of an application. In one or more embodiments, a Web browser provides a search box in which a user can enter a search query. While the user is entering a search query, the Web browser can communicate with a third-party search provider to receive information, such as non-textual information, which can be presented to the user to assist in formulating their search query. The non-textual information can include images and other visual information of a non-textual nature.

Abstract: An application provides a search box that is configured to enable a user to enter searchable text. The application provides a quick pick search provider menu that is configured to include different sections that provide suggestions as text is entered into the search box. At least some of the suggestions are locally maintained, and at least some other of the suggestions are received from one or more remote search providers. In some embodiments, the application can comprise a web browser.

Abstract: A Web browser includes a quick pick search provider menu that provides a user interface which provides a user with the ability to quickly select a new search provider which appears when the user places focus in the Web browser's search box. In one or more embodiments, the Web browser's search box comprises a native part of the Web browser and is not a search box associated with an installed tool bar. In other embodiments, search box functionality is provided as an extension to the Web browser. Further, various embodiments enable the user to switch between search providers in an easy and intuitive way. Yet other embodiments provide an opportunity for users to switch between search providers using keywords in the search box. Further embodiments enable users to define collections of search providers to which individual searches can be sent.

Abstract: The subject invention provides a pharmaceutical composition comprising: an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of a pharmaceutically acceptable salt of a) a peptide comprising at least 12 and at most 30 consecutive amino acids, b) a peptide comprising consecutive amino acids having the sequence shown by any of SEQ ID NOS. 8-17, c) a peptide comprising consecutive amino acids having a sequence of any of a) and b), or at least two sequences in (a), or d) a peptide comprising consecutive amino acids having a sequence comprising at least two identical sequences included in (a); and a solubility enhancer; and wherein the composition has a pH between 4 and 9, and a method of alleviating symptoms of SLE in a human by administering an effective amount of the composition.

Abstract: The subject invention provides a pharmaceutical composition comprising: an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a) a peptide comprising at least 12 and at most 30 consecutive amino acids having a sequence corresponding to (i) a sequence of amino acids found within a complementarity-determining region (CDR) of a heavy or a light chain of a human monoclonal anti-DNA 16/6 Id antibody, or (ii) a sequence of amino acids found within a complementarity-determining region (CDR) of a heavy or a light chain of a pathogenic anti-DNA monoclonal antibody that induces a systemic lupus erythematosus (SLE)-like disease response in mice, or b) a peptide comprising consecutive amino acids having the sequence shown by any of SEQ ID NOS.

Abstract: A Web browser includes a quick pick search provider menu that provides a user interface which provides a user with the ability to quickly select a new search provider which appears when the user places focus in the Web browser's search box. In one or more embodiments, the Web browser's search box comprises a native part of the Web browser and is not a search box associated with an installed tool bar. In other embodiments, search box functionality is provided as an extension to the Web browser. Further, various embodiments enable the user to switch between search providers in an easy and intuitive way. Yet other embodiments provide an opportunity for users to switch between search providers using keywords in the search box. Further embodiments enable users to define collections of search providers to which individual searches can be sent.

Abstract: Various embodiments enable information, in addition to textual information, to be presented to a user when the user enters a search query in a search box forming part of a user interface of an application. In one or more embodiments, a Web browser provides a search box in which a user can enter a search query. While the user is entering a search query, the Web browser can communicate with a third-party search provider to receive information, such as non-textual information, which can be presented to the user to assist in formulating their search query. The non-textual information can include images and other visual information of a non-textual nature.

Abstract: The subject invention provides a pharmaceutical composition comprising an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a peptide having the structural formula NH2-Gly Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Glu Glu Trp Ile Gly-COOH; and a substituted ?-cyclodextrin in an amount effective to dissolve the peptide in the aqueous carrier, wherein the composition has a pH between 4 and 9, a process for preparation, and a method of alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject comprising administering to the human subject the pharmaceutical composition.

Abstract: The subject invention provides a pharmaceutical composition comprising an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a peptide having the structural formula NH2-Gly Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Glu Glu Trp Ile Gly-COOH; and a substituted ?-cyclodextrin in an amount effective to dissolve the peptide in the aqueous carrier, wherein the composition has a pH between 4 and 9, a process for preparation, and a method of alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject comprising administering to the human subject the pharmaceutical composition.

Abstract: Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose are disclosed. Processes for the manufacture of such compositions are also disclosed.

Abstract: The subject invention provides a pharmaceutical composition comprising: an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a) a peptide comprising at least 12 and at most 30 consecutive amino acids having a sequence corresponding to (i) a sequence of amino acids found within a complementarity-determining region (CDR) of a heavy or a light chain of a human monoclonal anti-DNA 16/6 Id antibody, or (ii) a sequence of amino acids found within a complementarity-determining region (CDR) of a heavy or a light chain of a pathogenic anti-DNA monoclonal antibody that induces a systemic lupus erythematosus (SLE)-like disease response in mice, or b) a peptide comprising consecutive amino acids having the sequence shown by any of SEQ ID NOS.

Abstract: The subject invention provides a pharmaceutical composition comprising an aqueous carrier; from 0.